fashion -WSS

fashion

author：fashion 2025-08-19 12:15:06 - browse：9379

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： H5N1 bird flu outbreak: Second human case reported, in Michigan

Wikipedia

WSS

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

The strategy behind pharma's lawsuits over drug pricing reform

Scrutiny of post

UnitedHealth argues against case alleging wrongful AI care denials

Study finds gene variants tied to breast cancer risk in Black women

Eyeing GLP

hotspot

fashion

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Eyeing GLP

Cancer drug shortages should be causing more outrage

Listen: A conversation with researcher Kevin Esvelt on biosecurity

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why we need to separate burnout from moral injury in health care

How to save PrEP access — and even expand it

For longer

Medicare details structure of new drug price negotiation program

Why we need to separate burnout from moral injury in health care

leisure time

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Biogen joins immunology wave with $1.15 billion acquisition of HI

New guidelines on severe brain injury complicate already difficult decisions

Paxlovid study fails to answer questions over benefit for broader groups

Bird flu surveillance in wastewater gets boost from consortium

Eyeing GLP

Wikipedia

hotspot

Wikipedia

entertainment